Manipulation of immune regulation in systemic lupus erythematosus
- 30 November 2005
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 4 (8), 515-519
- https://doi.org/10.1016/j.autrev.2005.04.008
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and ParadoxesAnnual Review of Immunology, 2005
- IL‐10‐Producing T Regulatory Type 1 Cells and Oral ToleranceAnnals of the New York Academy of Sciences, 2004
- Interferon-α in systemic lupus erythematosusCurrent Opinion in Rheumatology, 2004
- Differences between CD8+ T cells in lupus-prone (NZB× NZW) F1 mice and healthy (BALB/c× NZW) F1 mice may influence autoimmunity in the lupus modelEuropean Journal of Immunology, 2004
- Anti B cell therapy (rituximab) in the treatment of autoimmune diseasesCurrent Opinion in Pharmacology, 2004
- BlySfulness Does Not Equal Blissfulness in Systemic Lupus Erythematosus: A Therapeutic Role for BLyS AntagonistsPublished by S. Karger AG ,2004
- Treatment of SLE with Anti-CD20 Monoclonal AntibodyPublished by S. Karger AG ,2004
- A short course of BG9588 (anti–CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritisArthritis & Rheumatism, 2003
- T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MRL/lpr miceEuropean Journal of Immunology, 2003
- Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus.JCI Insight, 1995